tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BRNS Stock Latest News

Barinthus Biotherapeutics Approves Key Proposals at AGM
Company AnnouncementsBarinthus Biotherapeutics Approves Key Proposals at AGM
2M ago
8K
BRNS
Barinthus Biotherapeutics: Strategic Advancements and Financial Strength Support Buy Rating
PremiumRatings
Barinthus Biotherapeutics: Strategic Advancements and Financial Strength Support Buy Rating
3M ago
BRNS
Barinthus Biotherapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Barinthus Biotherapeutics Reports Q1 2025 Financial Results
3M ago
BRNS
Barinthus Biotherapeutics Restructures Leadership with New CFO
PremiumCompany Announcements
Barinthus Biotherapeutics Restructures Leadership with New CFO
3M ago
8K
BRNS
Barinthus Biotherapeutics reports Q1 EPS (49c), consensus (36c)
PremiumThe Fly
Barinthus Biotherapeutics reports Q1 EPS (49c), consensus (36c)
3M ago
BRNS
Barinthus Bio Reports 2024 Financial Results and Strategic Focus
PremiumCompany AnnouncementsBarinthus Bio Reports 2024 Financial Results and Strategic Focus
4M ago
BRNS
Barinthus Biotherapeutics price target lowered to $6 from $7.50 at Alliance Global Partners
Premium
The Fly
Barinthus Biotherapeutics price target lowered to $6 from $7.50 at Alliance Global Partners
4M ago
BRNS
Barinthus Biotherapeutics reports FY24 EPS ($1.55), consensus ($1.48)
Premium
The Fly
Barinthus Biotherapeutics reports FY24 EPS ($1.55), consensus ($1.48)
5M ago
BRNS
Barinthus Biotherapeutics sees cash runway into 2027
PremiumThe Fly
Barinthus Biotherapeutics sees cash runway into 2027
5M ago
BRNS
BRNS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
BRNS Earnings this Week: How Will it Perform?
5M ago
BRNS
Barinthus price target lowered to $6 from $7.50 at Alliance Global Partners
PremiumThe Fly
Barinthus price target lowered to $6 from $7.50 at Alliance Global Partners
6M ago
BRNS
Barinthus Biotherapeutics price target lowered to $3 from $5 at H.C. Wainwright
PremiumThe Fly
Barinthus Biotherapeutics price target lowered to $3 from $5 at H.C. Wainwright
7M ago
BRNS
Barinthus Biotherapeutics Restructures to Focus on Immunotherapy
PremiumCompany AnnouncementsBarinthus Biotherapeutics Restructures to Focus on Immunotherapy
7M ago
8K
BRNS
Barinthus announces strategic focus in I&I, provides financial update
Premium
The Fly
Barinthus announces strategic focus in I&I, provides financial update
7M ago
BRNS
Barinthus Biotherapeutics Appoints New Chief Scientific Officer
Premium
Company Announcements
Barinthus Biotherapeutics Appoints New Chief Scientific Officer
8M ago
8K
BRNS
Barinthus CSO Nadege Pelletier to depart, Geoffrey Lynn to succeed
PremiumThe Fly
Barinthus CSO Nadege Pelletier to depart, Geoffrey Lynn to succeed
8M ago
BRNS
Barinthus Biotherapeutics Reports Promising IM-PROVE II Trial Results
PremiumCompany Announcements
Barinthus Biotherapeutics Reports Promising IM-PROVE II Trial Results
9M ago
8K
BRNS
Barinthus announces results from ongoing Phase 2b HBV003 trial
PremiumThe Fly
Barinthus announces results from ongoing Phase 2b HBV003 trial
9M ago
BRNS
Arbutus and Barinthus announce new data from IM-PROVE II trial
PremiumThe Fly
Arbutus and Barinthus announce new data from IM-PROVE II trial
9M ago
ABUS
BRNS
JMP Securities healthcare analysts hold an analyst/industry conference call
PremiumThe FlyJMP Securities healthcare analysts hold an analyst/industry conference call
9M ago
GSK
VIR
Barinthus Biotherapeutics reports Q3 EPS (21c), consensus (44c)
Premium
The Fly
Barinthus Biotherapeutics reports Q3 EPS (21c), consensus (44c)
9M ago
BRNS
JMP Securities healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
10M ago
GSK
VIR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >